CONNECTIVE TISSUE ONCOLOGY SOCIETY (EIN 541753869) - Form 990 Financial Analysis & Trantor Score

🔒

Tuckman-Chang Vulnerability Assessment

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1995

Legal Domicile

Principal Officer

BARBARA RAPP

Phone

3015027371

Tax Period

2023-01-01 to 2023-12-31

CONNECTIVE TISSUE ONCOLOGY SOCIETY, founded in 1995, is a community nonprofit in the Education sector that reported $2.2M in total revenue in fiscal year 2020. Revenue surged 107% from the prior year, signaling strong growth momentum. The organization ran a surplus of $1.0M, a strong 46% operating margin.

Mission

THE SOCIETY'S PURPOSE IS TO PROMOTE EDUCATION, RESEARCH , AND PATIENT CARE THROUGH THE ADVANCEMENT OF CONNECTIVE TISSUE ONCOLOGY AND ONCOLOGY RESEARCH.

🔒

Trantor Score

Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,101,094

Program Service Revenue $775,769

Investment Income $56,266

Other Revenue $0

TOTAL REVENUE $1,933,129

Expense Breakdown

Grants Paid $7,000

Salaries & Benefits $350,000

Fundraising Expenses $0

Program Expenses $1,317,445

Other Expenses $1,357,189

TOTAL EXPENSES $1,714,189

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,933,129	$1,806,146	+0.1%
Expenses	$1,714,189	$1,637,580	+0.0%
Net Income	$218,940	$168,566	+0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$350,000

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BARBARA RAPP	EXECUTIVE DIRECTOR	30	Officer	$350,000	$0	$350,000
WILLIAM TAP MD	PAST PRESIDENT	1	Officer Director	$0	$0	$0
CAROL SWALLOW MD PHD	PRESIDENT	2	Officer Director	$0	$0	$0
DAMON REED MD	VICE PRESIDENT	2	Officer Director	$0	$0	$0
SILVIA STACCHIOTI MD	SECRETARY	2	Officer Director	$0	$0	$0
ROBIN JONES MD	TREASURER	2	Officer Director	$0	$0	$0
BERND KASPER MD PHD	DIRECTOR	1	Director	$0	$0	$0
MARGARET VON MEHREN MD	DIRECTOR	1	Director	$0	$0	$0
E ALEJANDRO SWEET-CORDERO MD	DIRECTOR	1	Director	$0	$0	$0
INGA-MARIE SCHAEFER MD	DIRECTOR	1	Director	$0	$0	$0
HERBERT LOONG MD	DIRECTOR	1	Director	$0	$0	$0
CHANDRAJIT RAUT MD	DIRECTOR	1	Director	$0	$0	$0
NOAH FEDERMAN MD	DIRECTOR	1	Director	$0	$0	$0
SANDRA D'ANGELO MD	DIRECTOR	1	Director	$0	$0	$0
REBECCA GLADDY MD PHD	DIRECTOR	1	Director	$0	$0	$0
NADIA HINDI MD	DIRECTOR	1	Director	$0	$0	$0
TORSTEN NIELSON MD PHD	DIRECTOR	1	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$1,933,129	$1,714,189	$1,931,646	$218,940
2022	$1,806,146	$1,637,580	$1,703,294	$168,566
2021	$1,139,684	$1,165,243	$1,534,928	$-25,559
2020	$2,213,869	$1,196,532	$1,560,887	$1,017,337

CONNECTIVE TISSUE ONCOLOGY SOCIETY